Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000936
Chunk: 49

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 49
---
 the Commencement. All Purchase Shares and Commitment
Shares, if any, to be issued from and after the Commencement to or for the benefit of the Investor pursuant to this Agreement shall be
issued only as DWAC Shares. The Company represents and warrants to the Investor that, while this Agreement is in effect, no instruction
other than instruction letters in the form of the Depositary Instruction Letter referred to in this will be given by
the Company to the Depositary with respect to the Purchase Shares or the Commitment Shares, if any, from and after Commencement, and the
Purchase Shares and the Commitment Shares, if any, covered by the Registration Statement shall otherwise be freely transferable on the
books and records of the Company. If the Investor effects a sale, assignment or transfer of the Purchase Shares or the Commitment Shares,
if any, the Company shall permit the transfer and shall promptly instruct the Depositary (and any subsequent depositary) to issue DWAC
Shares in such name and in such denominations as specified by the Investor to effect such sale, transfer or assignment. The Company acknowledges
that a breach by it of its obligations hereunder will cause irreparable harm to the Investor. Accordingly, the Company acknowledges that
the remedy at law for a breach of its obligations under this will be inadequate and agrees, in the event of a breach
or threatened breach by the Company of the provisions of this , that the Investor shall be entitled, in addition to all
other available remedies, to seek an order and/or injunction restraining any breach and requiring immediate issuance and transfer, without
the necessity of showing economic loss and without any bond or other security being required.

| 7. | CONDITIONS TO THE COMPANY’S RIGHT TO COMMENCE |

SALES OF SHARES OF DEPOSITARY SHARES.

The right of the Company hereunder
to commence sales of the Purchase Shares as of the Commencement Date is subject to the satisfaction of each of the following conditions:

(a) The Investor shall
have executed each of the Transaction Documents and delivered the same to the Company;

(b) The Registration
Statement covering the resale of up to 35,000,000 Purchase Shares and up to 875,000 Commitment Shares shall have been declared effective
under the Securities Act by the SEC, and no stop order with respect to the Registration Statement shall be pending or threatened by the
SEC; and

(c) The representations
and warranties of the Investor shall be true and correct in all material respects as of the Execution